Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",platelet size trait,,RS:0004632,SD-Fhem1+/-,male,0 days,3,,CMO:0003233,platelet-large cell ratio,,,,16.5,%,1.4434,2.5,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104921,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",platelet size trait,,RS:0004632,SD-Fhem1+/-,male,0 days,3,,CMO:0003233,platelet-large cell ratio,,,,11.7,%,2.1939,3.8,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104923,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",platelet size trait,,RS:0004632,SD-Fhem1+/-,female,0 days,3,,CMO:0003233,platelet-large cell ratio,,,,16.1,%,1.6166,2.8,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104924,control condition